Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Innovations in Diabetes and Metabolic Care Fall 2024

Showing   of 2 results

Hands with blue gloves are preparing infusion IV drip

University Hospitals Offers Infusion Shown to Delay Progression of Type 1 Diabetes

Innovations in Diabetes & Metabolic Care | Fall 2024

Close up image of pancreatic cells

FDA Approval of Islet Cell Transplant Marks Milestone for UH’s Leading Endocrinologist

Innovations in Diabetes & Metabolic Care | Fall 2024 In 2023, the U.S. Food and Drug Administration (FDA) approved Lantidra™ (donislecel), a breakthrough allogeneic (donor) pancreatic islet cellular therapy for individuals with Type 1 diabetes...

Results are loading...